Healthcare Compliance

ZIPHYCARE Medical Diagnostic Kit, Cable Management, Multi-Port Hubs

The USPTO granted Patent US12609198B2 to ZIPHYCARE INC covering a medical diagnostic kit (MDK) with universal cable storage compartments, switchable multi-port hubs, and integrated diagnostic computer capabilities. The patent includes 25 claims and classifies under health informatics (G16H) and medical device (A61B) categories. The invention facilitates remote real-time medical examinations through configurable cable management and media conference connectivity.

DEEPX Neural Processor Predicts Cardiovascular Disease Using AI

USPTO granted Patent US12609200B2 to DEEPX CO., LTD. for a neural processing unit that implements an artificial neural network model to predict cardiovascular disease onset. The ANN model processes sensing data from ECG, respiration, pulse rate, acceleration, and body temperature to output probabilities for cerebral infarction, heart failure, and ischemic heart disease.

TouchDx Medical Surveillance Patent US12609197B2

USPTO granted patent US12609197B2 to TouchDx for a medical monitoring and surveillance system. The system uses a server communicating with a general-purpose personal device running a downloadable application that configures the device to perform medical tests using built-in sensors and functionality. The application reports test results to the server or a third party, with trigger events initiating associated tasks when predetermined criteria are met.

Cardiac Arrest Resuscitation Patent, US12609190B2

The USPTO granted patent US12609190B2 on April 21, 2026 to inventors Tamara Aliza Freeman and Michelle Alyssa Freeman. The patent covers cardiac arrest resuscitation methods and equipment including a manual or automatic Pocket Crash Cart that attaches to patients via IV or OS for quick emergency medication administration. The patent also covers software for mirroring defibrillator and AED displays and transmitting patient information to medical professionals via internet for expert advice in hard-to-reach locations.

US12609192B2 - Direct Supply Inc. - Automated Dietary Management in Healthcare Facilities

The USPTO granted Patent US12609192B2 to Direct Supply, Inc. on April 21, 2026. The patent covers systems, methods, and media for automated dietary management in healthcare facilities. The application (No. 18899885) was filed on September 27, 2024, and the patent contains 18 claims.

CDW LLC AI Patient Intake Patent, Apr 21

USPTO granted Patent US12609196B2 to CDW LLC on April 21, 2026. The patent covers AI-based technologies for improving patient intake, including NLP processing of verbal patient responses, care plan generation, and routing to recipient entities. The application was filed December 5, 2024 with 17 claims.

ATOS PUBLIC SAFETY LLC Health Record Patent US12609188B2 Granted

USPTO granted patent US12609188B2 to ATOS PUBLIC SAFETY LLC on April 21, 2026, covering a method for providing health record data. The patent describes generating victim datasets, matching them with private information at predefined probability thresholds, aggregating activity information from multiple databases, and selecting best-matching aggregated information for data retrieval. The patent contains 11 claims and was filed on May 17, 2023.

US12609189B2 Care Plan Recommendation System with GPT Wound Analysis

The USPTO granted Patent US12609189B2 to Industrial Technology Research Institute on April 21, 2026, covering a care plan recommendation method and system that uses GPT to analyze wound images and generate dressing usage results and care instructions. The patent claims 12 items across multiple CPC classifications in health informatics.

USPTO Grants Patent US12609187B2 for Clinical Budget Data Transformation

USPTO granted patent US12609187B2 to Annex IP, LLC on April 21, 2026 for a computer-implemented method of reconciling clinical trial budgets. The system receives procedural items from sponsor budget, Medicare Coverage Analysis, and site charge master sources; normalizes text and generates vector embeddings; constructs approximate nearest-neighbor indices; retrieves candidates by cosine similarity; computes composite match scores combining code equality, textual similarity, numeric price proximity, and billing consistency; selects one-to-one matches via maximum-weight bipartite matching; aligns to Medicare Coverage Analysis items with code-family gating; and writes per-item audit records through an API. The patent contains 20 claims and is classified under CPC G16H 10/20.

FDA Exhibit 58 Background Material Apr 21

FDA filed Exhibit 58 as background material in administrative docket FDA-2026-P-4112. The exhibit supports the administrative record with supplementary documentation. No substantive obligations, deadlines, or enforcement actions are described in the available content.

USAN Council Adopts TAM Nonproprietary Name

The USAN Council, operating in cooperation with the FDA, has adopted the nonproprietary name 'TAM' for a substance. The adopted name has been filed with the FDA as a public notice. This naming action establishes the official United States Adopted Name for the substance, which will serve as its standard nonproprietary designation in pharmaceutical and medical contexts.

USAN Council Issues Statement on Aliskiren Fumarate Naming

The United States Adopted Names (USAN) Council issued a statement assigning the official non-proprietary name 'aliskiren fumarate' for the drug compound. This designation provides the standardized USAN name that pharmaceutical manufacturers must use in labeling, applications, and communications. The statement was filed with the FDA as document FDA-2026-P-4112.

Zyloprim Approval Package Background Material

FDA published the background material for the Zyloprim (allopurinol) approval package. Zyloprim is a xanthine oxidase inhibitor used to treat gout and conditions involving elevated uric acid. The document is available for download from Regulations.gov as FDA-2026-P-4112-0070.

Novothyrox Prescribing Information From May 2002

FDA received a filing containing historical prescribing information for Novothyrox (a thyroid medication) originally dated May 2002. The document is available as a PDF attachment via regulations.gov. No new regulatory requirements, compliance obligations, or enforcement actions are described.

VEMLIDY Exclusivity Summary

FDA posted an exclusivity summary for VEMLIDY (tenofovir alafenamide), a hepatitis B treatment marketed by Gilead Sciences. The document was filed to the regulatory docket on April 21 and is accessible via regulations.gov. The posted content consists of a download link to the PDF; no substantive exclusivity determination text is visible in the source.

Orange Book 46th Edition

The FDA has published the 46th edition of the Orange Book (Approved Drug Products with Therapeutic Equivalence Evaluations). The Orange Book is the authoritative FDA reference listing approved prescription drug products, including patent and exclusivity information used by generic drug manufacturers, pharmacy benefit managers, and healthcare payers to assess therapeutic equivalence.

FDA Crystallography Toolbox, Small Molecule Structure Determination

The FDA published a Crystallography Toolbox document on Regulations.gov to support small molecule structure determination in pharmaceutical research and development. The document, filed as FDA-2026-P-4112-0049, provides technical resources for analytical chemistry applications. Access to the full content is restricted due to copyright limitations.

FDA Closes Complaint on Potential Regulatory Violation

FDA's Center for Tobacco Products filed complaint FDA-2026-H-4016 alleging a potential regulatory violation. The complaint was closed on April 21, 2026, with no further visible action taken. The document listing on regulations.gov contains no downloadable attachments or enforcement details.

Kuballa NMR Spectroscopy Transitions to Multi-Analysis Method

FDA filed a response to a petition from Kuballa regarding NMR spectroscopy methodology transitioning to a multi-analysis method. The document, filed under docket FDA-2026-P-4112, is available as a downloadable PDF attachment. No compliance obligations, deadlines, or penalties are stated in the available source content.

GE 2024 Financial Exhibit, FDA Regulatory Document, Restricted

A financial exhibit for 2024 filed by GE with the FDA, catalogued on regulations.gov under docket FDA-2026-P-4112-0081. The substantive content of the exhibit is not publicly available as it is restricted due to copyright.

Bristol-Myers Squibb FDA Response to Thomas Hayes M.D

Bristol-Myers Squibb submitted a response to FDA on regulations.gov regarding Thomas Hayes M.D. The document is accessible via a PDF download link. No substantive content text is visible in the source.

HRSA Health Center Program Forms OMB Review

HRSA has submitted an information collection request to OMB for revised Health Center Program forms under OMB No. 0915-0285. The notice requests public comment on the paperwork burden and substance of the revised forms. The comment period closes 30 days from the April 22, 2026 publication date.

Two Confirmed Measles Cases Identified in Virginia Northwest Region

The Virginia Department of Health confirmed two measles cases in the Northwest Region on April 21, 2026 — a preschool-age child (0–4 years) and a school-age child (5–12 years) who traveled together domestically. Exposure sites include KidMed Stafford Urgent Care (April 16, 4:30–8 p.m.) and Grafton Village Elementary School in Fredericksburg (April 9–10, April 13–16, and April 20). Virginia has recorded 19 measles cases in 2026 to date. Exposed individuals are advised to report via VDH survey, verify MMR vaccination status, monitor for symptoms for 21 days, and contact healthcare providers if not fully vaccinated or symptomatic.

Pilot Study Evaluates Occupational Health Data for Radiation Effects

UKHSA has announced a pilot study to evaluate approximately 7,000 electronically stored occupational health records from Springfields Fuels Ltd, assessing data on smoking, alcohol consumption, blood pressure, obesity, and asbestos exposure. The study will match this health and lifestyle information to workers in the National Registry of Radiation Workers (NRRW) to determine if such data can improve the accuracy of radiation risk estimates for common diseases. Upon completion, the dataset will be deleted while extraction and matching programs are retained for potential future use.

INWORKS2 Study: Radiation Dose-Response Findings for Nuclear Workers

UKHSA has published findings from the INWORKS2 study, an update to the International Nuclear Workers Study coordinated by the International Agency for Research on Cancer (IARC). The INWORKS2 dataset covers 309,932 nuclear workers across France, the UK, and the US with follow-up from 1944 to 2016, representing a 56% increase in deaths (to 103,553) and an additional 3 million person-years of observation compared to the original INWORKS dataset. The study examines dose-response relationships between cumulative external radiation exposure and mortality from solid cancers, haematological cancers, and non-cancer outcomes.

NRRW Radiation Worker Cohort: Non-Melanoma Skin Cancer and Ischaemic Heart Disease Dose-Response Studies

UKHSA published results from two studies based on the National Registry for Radiation Workers (NRRW) cohort examining radiation dose-response relationships for non-melanoma skin cancer (NMSC) and ischaemic heart disease (IHD) mortality. The NMSC study (172,452 workers, 5.25 million person-years) found that basal cell carcinoma (BCC) risk increased with cumulative radiation dose but the association was largely explained by ultraviolet radiation exposure based on tumour location. The IHD study (174,541 workers, 9,814 deaths) found a statistically significant excess relative risk of 0.32 per sievert, with a linear-quadratic dose-response relationship exhibiting downward curvature at doses above 0.4 Sv. Both studies were published in peer-reviewed journals (International Journal of Cancer and Journal of Radiological Protection) and represent open-access findings from the NRRW third analysis with extended follow-up.

INWORKS: Collaborative Study on Nuclear Workers Using NRRW Data

UKHSA published guidance on the International Nuclear Workers Study (INWORKS), an epidemiological study coordinated by IARC that pools data from 308,297 nuclear workers in the UK, US and France. The study found a statistically significant association between radiation dose and mortality from solid cancers (48% increase per Sv), leukaemia (2.96 per Sv), and circulatory diseases (22% per Sv). Mean follow-up was 27 years with 66,632 deaths observed. Mean individual cumulative external dose was 25 mSv over the monitoring period.

National Registry for Radiation Workers Guidance Published by UKHSA

UKHSA published guidance on the National Registry for Radiation Workers (NRRW), a long-running UK epidemiological study established in 1976 to monitor health effects of low-dose occupational radiation exposure. The registry currently holds data on over 270,000 workers from nuclear industry employers including the Ministry of Defence, former British Nuclear Fuels Ltd sites, UK Atomic Energy Authority, and nuclear power generation sites. The study operates an opt-out policy with an estimated opt-out rate of approximately 1%, allowing workers to request exclusion at any time via email.

National Registry Radiation Workers UK GDPR Privacy Notice

UKHSA published its privacy notice for the National Registry for Radiation Workers (NRRW), explaining how personal data is collected, processed, and protected under UK GDPR. The registry covers radiation workers employed by participating organisations since 1976, with retrospective data going back to the late 1940s, collecting identifying information, employment details, and radiation exposure data. Individual personal data is not shared outside UKHSA, though aggregated data may be shared with international collaborating scientists for combined cohort analyses.

Merger of BNFL, UKAEA and AWE Worker Epidemiology Studies into NRRW

UKHSA has published guidance on the planned merger of three long-term epidemiological studies of nuclear radiation workers into the National Registry for Radiation Workers (NRRW). The three studies—covering workers from British Nuclear Fuels Ltd (BNFL), UK Atomic Energy Authority (UKAEA), and the Atomic Weapons Establishment (AWE)—will be merged on 1 January 2024, creating a single national resource to study radiation risks with increased statistical power. The merger adds approximately 30,000 workers monitored for internal radiation exposure and introduces a non-radiation worker comparison group to account for the healthy worker effect.

Rabid Raccoon Confirmed in Kershaw County; Two Horses Exposed

The South Carolina Department of Public Health confirmed a raccoon found near Bishopville Highway and Lee Road in Camden tested positive for rabies on April 20, 2026, after being submitted for testing on April 17. Two horses were exposed and will be quarantined as required under the South Carolina Rabies Control Act; no human exposures are known at this time. This is the first rabid animal case in Kershaw County in 2026, with 25 cases reported statewide this year and 101 confirmed cases in 2025.

DPH Encourages Residents to Dispose of Unused Prescription Medicines During Drug Take Back Day

SC DPH is encouraging South Carolina residents to participate in the DEA-hosted National Prescription Drug Take Back Day on Saturday, April 25, 2026, from 10 a.m. to 2 p.m., by disposing of unused or expired prescription medications at designated collection sites. The announcement cites state data showing 2,157 drug overdose deaths in 2023 (6.1% decrease from 2022), with 1,840 attributed to prescription drugs, and 1,479 provisional deaths in 2024. Drop-off sites will collect tablets, capsules, patches, and solid prescription drugs; vaping devices, liquids, sharps, and illegal drugs will not be accepted. Free Overdose Prevention Safety Kits containing fentanyl test strips, naloxone (Narcan), and treatment resources are available at DPH health clinics without appointments or ID.

No New Measles Cases Since Friday, Outbreak Total Stays 997

South Carolina DPH reported no new measles cases on April 21, 2026, keeping the Upstate outbreak total at 997 cases. Forty-one individuals remain in quarantine related to a Saluda County exposure, with quarantine ending May 9. If no new outbreak-related cases are reported, the outbreak would end April 26, following a 42-day period with no new cases.

Boil Water Advisory Rescinded for City of Fort Scott Bourbon County

KDHE has rescinded the boil water advisory for the City of Fort Scott public water supply system in Bourbon County, Kansas, effective April 21, 2026. The advisory was originally issued due to a waterline break causing loss of pressure in the distribution system, which risked bacteriological contamination from reduced chlorine residuals. Laboratory testing of drinking water samples collected from the City of Fort Scott showed no evidence of bacteriological contamination, and KDHE officials confirmed all conditions that placed the system at risk are resolved. The advisory remains in effect for Bourbon Co RWD 2C and City of Uniontown public water supply systems.

Boil Water Advisory Rescinded for Jefferson Co RWD 7, Jefferson County

KDHE has rescinded a boil water advisory for Jefferson Co RWD 7 public water supply system in Jefferson County, effective April 21, 2026. The advisory was originally issued on April 16, 2026 due to a waterline break that caused a loss of pressure in the distribution system, which risked chlorine residual loss and bacterial contamination. Laboratory testing of drinking water samples confirmed no bacteriological contamination, and KDHE officials have determined all conditions that placed the system at risk are resolved.

Method for Determining Respiratory Timing Parameters from Respiratory Monitoring Measurements

The USPTO granted Patent US12605088B2 to Onera Technologies B.V. on April 21, 2026, covering a method for deriving respiratory timing parameters from respiratory monitoring measurements. The patent discloses a computational method involving respiratory effort and flow signal analysis to identify and refine inspiratory onset times using derivative analysis within peak-to-peak intervals. The patent contains 20 claims and names Alessandro Rossi and Hartmut Schneider as inventors.

Flexible Instrument Localization from Both Remote and Elongation Sensors

The USPTO granted Patent US12605086B2 to Auris Health, Inc. covering a system and method for tracking flexible elongate instruments within patients. The system combines remote localization measurement data with elongation measurement data, transforming both to a coordinate reference frame to produce more accurate instrument localization than either data source alone. The patent names five inventors: Sean Walker, Dave Camarillo, Matt Roelle, Christopher Sewell, and Aditya Koolwal.

Synchronized Aspiration System with Catheter Sensors for Removal of Acute Blockages from Blood Vessels

USPTO granted Patent US12605499B2 to Neuravi Limited on April 21, 2026, covering a synchronized aspiration catheter system with integrated electrode pairs and pressure sensors for removing acute blood clots from patient vessels. The control console modulates aspiration vacuum pressure based on sensor inputs and optionally the patient's blood pressure waveform. The patent application was filed May 12, 2022, under application number 17743121, with 9 claims.

Method and Apparatus for Continuous Vitals Monitoring - US12605078B2

USPTO granted Patent US12605078B2 to Rythmos LLC for a health monitoring device using fiber Bragg grating (FBG) sensors to detect physiological attributes. The device places FBG sensors in contact with skin near arteries or veins to measure refractive index changes and estimates physiological attributes based on strain-induced Bragg wavelength shifts. The patent contains 20 claims.

MRI and Focused Ultrasound Thermal Ablation System

USPTO granted patent US12605071B2 to Shanghai Shende Green Medical Era Healthcare Technology Co., Ltd. for a compatible system enabling synchronized operation of magnetic resonance imaging and focused ultrasound thermal ablation. The system includes a signal collector and control circuit that detects MRI radio frequency signals, records trigger times, and controls focused ultrasound heating duration. The patent contains 8 claims.

Photoplethysmogram System Patent, Multiple Light Sources

The USPTO granted Patent US12605077B2 to PranaQ Pte. Ltd. for a photoplethysmogram (PPG) system using multiple light sources of different frequencies (red, infrared, green). The system includes a PPG sensor that detects light after passage through a subject's skin and a processor that estimates physiological parameters including blood oxygen saturation, respiratory effort, pulse rate, and pulse rate variability. The patent contains 12 claims and covers dynamic signal processing methods including calibration using a green light source and imputation of inconsistent PPG signals.

Photoacoustic and Ultrasonic Imaging Device, OPTICHO INC

USPTO issued Patent No. US12605072B2 to OPTICHO INC., LTD. for a photoacoustic and ultrasonic imaging device that combines laser light and ultrasonic wave technologies for tissue imaging. The patent covers an imaging probe with a laser emitter and ultrasonic transducer, and an operation unit for image formation from photoacoustic and ultrasonic signals. 19 claims were granted.

Impedance Cardiography Device Patent, Tallinn University, Apr 21

The USPTO granted patent US12605084B2 to Tallinn University of Technology on April 21, 2026, covering an impedance cardiography device. The device includes an impedance measuring unit, differentiator, comparator, microcontroller with analog-to-digital converter, and two peak voltage detection units with different polarities. The patent contains 8 claims and was filed on March 27, 2023 under Application No. 18190622.

Physiological Sensor Delivery Device - US12605075B2

USPTO granted patent US12605075B2 to ACIST Medical Systems, Inc. on April 21, 2026, covering an intravascular sensor delivery device and method for measuring physiological parameters such as blood pressure within vascular structures. The device is sized to pass over guidewires for use in coronary and peripheral arteries and can measure pressure gradients across stenotic lesions or heart valves. The patent contains 19 claims with a filing date of April 19, 2021.

Adaptive Pulse Wave Analysis for Blood Pressure Monitoring

The USPTO granted Patent US12605080B2 to Senbiosys on April 21, 2026. The patent covers an adaptive signal processing technique for pulse wave analysis that improves blood pressure estimation by transforming the pulsatility signal to define fiducial points more precisely. The patent application (No. 17455540) was filed on November 18, 2021, and contains 15 claims.

US12605079B2 Physiological Parameter Measurement System, Sonion Nederland

The USPTO granted Patent US12605079B2 to Sonion Nederland B.V. for a system and method measuring physiological parameters of blood-perfused tissue using dual radiation sensors—one sensor measures blood volume via radiation absorption, while the second measures blood flow speed via Doppler shift—with a controller determining the physiological parameter from both data streams. The patent contains 13 claims and covers CPC classifications in the A61B medical diagnosis category.

Neuroptics Inc. Anisocoria Monitoring Patent US12605066B2 Granted April 21 2026

The USPTO granted patent US12605066B2 to Neuroptics, Inc. on April 21, 2026, covering methods, systems, and devices for monitoring anisocoria and asymmetry of pupillary reaction to stimulus. The patent discloses synchronized recording and display of bilateral pupil response images in response to the same stimulus. The patent contains 3 claims and spans multiple CPC classifications including A61B 3/112, A61B 3/14, and related medical device and healthcare informatics categories.

Optical element movement mechanism for multi-modality ophthalmic imaging systems

USPTO granted US Patent 12605067B2 to Optos plc for an optical element movement mechanism in multi-modality ophthalmic imaging systems. The mechanism rotates optical elements to alternate between imaging modes by moving elements into and out of optical paths. The patent contains 14 claims.

Washington University Cardiac Ablation Patent Granted

The USPTO granted US Patent 12605070B2 to Washington University covering a method for selecting ablation targets for non-invasive cardiac arrhythmia treatment using segmented mapping models. The patent names Clifford Robinson, Phillip Cuculich, and Geoffrey Hugo as inventors and contains 13 claims with filing date May 31, 2022.

Olympus Winter & Ibe Patent for Albarran and Pull Wire Carrier

The USPTO granted patent US12605052B2 to Olympus Winter & Ibe GmbH for an Albarran and pull wire carrier assembly used in endoscopic instruments. The invention includes a pull wire carrier with a through-bore for a tubular shaft and a receptacle for a releasable cover element, with pull wires fixable between the carrier and cover. The patent contains 12 claims.